An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3‐L1 adipocytes

Authors:
  • HMHiroaki Masuzaki
    Hiroaki Masuzaki
  • TTTomohiro Tanaka
    Tomohiro Tanaka
  • SYShintaro Yasue
    Shintaro Yasue
  • TTTsutomu Tomita
    Tsutomu Tomita
  • KOKayoko Okazawa
    Kayoko Okazawa
  • JFJunji Fujikura
    Junji Fujikura
  • HCHideki Chusho
    Hideki Chusho
  • KEKen Ebihara
    Ken Ebihara
  • KHKiminori Hosoda
    Kiminori Hosoda
  • KNKazuwa Nakao
    Kazuwa Nakao

Abstract
Evidence has accumulated that some of the angiotensin II AT1 receptor antagonists have insulin‐sensitizing property. We thus examined the effect of telmisartan on insulin action using 3T3‐L1 adipocytes. With standard differentiation inducers, a higher dose of telmisartan effectively facilitated differentiation of 3T3‐L1 preadipocytes. Treatment of both differentiating adipocytes and fully differentiated adipocytes with telmisartan caused a dose‐dependent increase in mRNA levels for PPARγ target genes such as aP2 and adiponectin. By contrast, telmisartan attenuated 11β‐hydroxysteroid dehydrogenase type 1 mRNA level in differentiated adipocytes. Of note, we demonstrated for the first time that telmisartan augmented GLUT4 protein expression and 2‐deoxy glucose uptake both in basal and insulin‐stimulated state of adipocytes, which may contribute, at least partly, to its insulin‐sensitizing ability.

This publication has 38 references indexed in Scilit: